{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:52:39Z","timestamp":1784865159241,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08163-5","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:55:59Z","timestamp":1777028159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["m6A-Mediated epitranscriptional reprogramming drives cardiac fibrosis by suppressing PGC-1\u03b1 and boosting mitochondrial fission"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiao-Ying","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Rui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jie","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Cai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Jun","family":"Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Jiu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"6","key":"8163_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","volume":"117","author":"NG Frangogiannis","year":"2021","unstructured":"Frangogiannis NG. Cardiac fibrosis. Cardiovasc Res. 2021;117(6):1450\u201388. https:\/\/doi.org\/10.1093\/cvr\/cvaa324.","journal-title":"Cardiovasc Res"},{"key":"8163_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","volume":"65","author":"NG Frangogiannis","year":"2019","unstructured":"Frangogiannis NG. Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Aspects Med. 2019;65:70\u201399. https:\/\/doi.org\/10.1016\/j.mam.2018.07.001.","journal-title":"Mol Aspects Med"},{"issue":"10","key":"8163_CR3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/eurheartj\/ehz786","volume":"41","author":"C Sohns","year":"2020","unstructured":"Sohns C, Marrouche NF. Atrial fibrillation and cardiac fibrosis. Eur Heart J. 2020;41(10):1123\u201331. https:\/\/doi.org\/10.1093\/eurheartj\/ehz786.","journal-title":"Eur Heart J"},{"key":"8163_CR4","doi-asserted-by":"publisher","first-page":"101194","DOI":"10.1016\/j.mam.2023.101194","volume":"93","author":"S Ravassa","year":"2023","unstructured":"Ravassa S, L\u00f3pez B, Treibel TA, San Jos\u00e9 G, Losada-Fuentenebro B, Tapia L, et al. Cardiac fibrosis in heart failure: focus on non-invasive diagnosis and emerging therapeutic strategies. Mol Aspects Med. 2023;93:101194. https:\/\/doi.org\/10.1016\/j.mam.2023.101194.","journal-title":"Mol Aspects Med"},{"key":"8163_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.addr.2021.03.021","volume":"173","author":"M Liu","year":"2021","unstructured":"Liu M, L\u00f3pez de Juan Abad B, Cheng K. Cardiac fibrosis: myofibroblast-mediated pathological regulation and drug delivery strategies. Adv Drug Deliv Rev. 2021;173:504\u201319. https:\/\/doi.org\/10.1016\/j.addr.2021.03.021.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"8163_CR6","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ymthe.2024.01.037","volume":"32","author":"ZY Liu","year":"2024","unstructured":"Liu ZY, Lin LC, Liu ZY, Yang JJ, Tao H. Tao H: m6A epitranscriptomic and epigenetic crosstalk in cardiac fibrosis. Mol Ther. 2024;32(4):878\u201389. https:\/\/doi.org\/10.1016\/j.ymthe.2024.01.037.","journal-title":"Mol Ther"},{"key":"8163_CR7","doi-asserted-by":"publisher","first-page":"155626","DOI":"10.1016\/j.metabol.2023.155626","volume":"145","author":"LC Lin","year":"2023","unstructured":"Lin LC, Tu B, Song K, Liu ZY, Sun H, Zhou Y, et al. Mitochondrial quality control in cardiac fibrosis: epigenetic mechanisms and therapeutic strategies. Metabolism. 2023;145:155626. https:\/\/doi.org\/10.1016\/j.metabol.2023.155626.","journal-title":"Metabolism"},{"issue":"25","key":"8163_CR8","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1093\/eurheartj\/ehaf130","volume":"46","author":"B Tu","year":"2025","unstructured":"Tu B, Song K, Zhou ZY, Lin LC, Liu ZY, Sun H, et al. SLC31A1 loss depletes mitochondrial copper and promotes cardiac fibrosis. Eur Heart J. 2025;46(25):2458\u201374. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf130.","journal-title":"Eur Heart J"},{"issue":"2","key":"8163_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.7150\/ijbs.87535","volume":"20","author":"L Ma","year":"2024","unstructured":"Ma L, Chang X, Gao J, Zhang Y, Chen Y, Zhou H, et al. METTL3 boosts mitochondrial fission and induces cardiac fibrosis after ischemia\/reperfusion injury. Int J Biol Sci. 2024;20(2):433\u201345. https:\/\/doi.org\/10.7150\/ijbs.87535.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"8163_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12933-024-02444-3","volume":"23","author":"ZY Liu","year":"2024","unstructured":"Liu ZY, Lin LC, Liu ZY, Song K, Tu B, Sun H, et al. N6-methyladenosine-mediated phase separation suppresses NOTCH1 expression and promotes mitochondrial fission in diabetic cardiac fibrosis. Cardiovasc Diabetol. 2024;23(1):347. https:\/\/doi.org\/10.1186\/s12933-024-02444-3.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"8163_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cell.2004.09.016","volume":"119","author":"SM Houten","year":"2004","unstructured":"Houten SM, Auwerx J. PGC-1\u03b1. Cell. 2004;119(1):5\u20137. https:\/\/doi.org\/10.1016\/j.cell.2004.09.016.","journal-title":"Cell"},{"issue":"11","key":"8163_CR12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.121.055727","volume":"145","author":"L Zhuang","year":"2022","unstructured":"Zhuang L, Jia K, Chen C, Li Z, Zhao J, Hu J, et al. DYRK1B-STAT3 drives cardiac Hypertrophy and heart failure by impairing mitochondrial bioenergetics. Circulation. 2022;145(11):829\u201346. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.055727.","journal-title":"Circulation"},{"issue":"1","key":"8163_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41392-023-01638-7","volume":"8","author":"C Wang","year":"2023","unstructured":"Wang C, Hou X, Guan Q, Zhou H, Zhou L, Liu L, et al. RNA modification in cardiovascular disease: implications for therapeutic interventions. Sig Transduct Target Ther. 2023;8(1):412. https:\/\/doi.org\/10.1038\/s41392-023-01638-7.","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"8163_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Sig Transduct Target Ther. 2021;6(1):74. https:\/\/doi.org\/10.1038\/s41392-020-00450-x.","journal-title":"Sig Transduct Target Ther"},{"key":"8163_CR15","doi-asserted-by":"publisher","first-page":"105910","DOI":"10.1016\/j.phrs.2021.105910","volume":"173","author":"T Xue","year":"2021","unstructured":"Xue T, Qiu X, Liu H, Gan C, Tan Z, Xie Y, et al. Epigenetic regulation in fibrosis progress. Pharmacological Res. 2021;173:105910. https:\/\/doi.org\/10.1016\/j.phrs.2021.105910.","journal-title":"Pharmacological Res"},{"key":"8163_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2023.07.003","volume":"207","author":"ZY Liu","year":"2023","unstructured":"Liu ZY, Song K, Tu B, Lin LC, Sun H, Zhou Y, et al. Glycolytic reprogramming in organ fibrosis: new dynamics of the epigenetic landscape. Free Radical Biol & Med. 2023;207:1\u201310. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.07.003.","journal-title":"Free Radical Biol & Med"},{"issue":"17","key":"8163_CR17","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1093\/cvr\/cvae239","volume":"120","author":"JF Ding","year":"2024","unstructured":"Ding JF, Tu B, Song K, Liu ZY, Lin LC, Liu ZY, et al. Epitranscriptomic regulation of cardiac fibrosis via YTHDF1-dependent PIEZO2 mRNA m6A modification. Cardiovasc Res. 2024;120(17):2236\u201348. https:\/\/doi.org\/10.1093\/cvr\/cvae239.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"8163_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/cvr\/cvaf257","volume":"122","author":"YS Zhang","year":"2026","unstructured":"Zhang YS, Liu ZY, Lin LC, Tu B, Mao S, Song K, et al. Epigenetic blockade of SOD2 boosts mitochondria ROS and cytoskeleton remodelling in cardiac fibrosis. Cardiovasc Res. 2026;122(1):66\u201380. https:\/\/doi.org\/10.1093\/cvr\/cvaf257.","journal-title":"Cardiovasc Res"},{"issue":"20","key":"8163_CR19","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1161\/CIRCULATIONAHA.117.028752","volume":"139","author":"E Villalobos","year":"2019","unstructured":"Villalobos E, Criollo A, Schiattarella GG, Altamirano F, French KM, May HI, et al. Fibroblast primary cilia are required for cardiac fibrosis. Circulation. 2019;139(20):2342\u201357. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.028752.","journal-title":"Circulation"},{"issue":"6","key":"8163_CR20","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.7150\/thno.47354","volume":"11","author":"Z Han","year":"2021","unstructured":"Han Z, Wang X, Xu Z, Cao Y, Gong R, Yu Y, et al. ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1. Theranostics. 2021;11(6):3000\u201316. https:\/\/doi.org\/10.7150\/thno.47354.","journal-title":"Theranostics"},{"issue":"8","key":"8163_CR21","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.7150\/thno.103809","volume":"15","author":"H Sun","year":"2025","unstructured":"Sun H, Qiao X, Peng X, Zhu H, Zhang L, Jiang L, et al. The m6A modification of SOX18 leads to increased PTX3 and cardiomyocyte pyroptosis in sepsis-induced cardiomyopathy. Theranostics. 2025;15(8):3532\u201350. https:\/\/doi.org\/10.7150\/thno.103809.","journal-title":"Theranostics"},{"issue":"1","key":"8163_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-021-01447-y","volume":"21","author":"W Wan","year":"2022","unstructured":"Wan W, Ao X, Chen Q, Yu Y, Ao L, Xing W, et al. METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer. Mol Cancer. 2022;21(1):60. https:\/\/doi.org\/10.1186\/s12943-021-01447-y.","journal-title":"Mol Cancer"},{"issue":"12","key":"8163_CR23","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1080\/15548627.2019.1596494","volume":"15","author":"H Xian","year":"2019","unstructured":"Xian H, Liou YC. Loss of MIEF1\/MiD51 confers susceptibility to BAX-mediated cell death and PINK1-PRKN-dependent mitophagy. Autophagy. 2019;15(12):2107\u201325. https:\/\/doi.org\/10.1080\/15548627.2019.1596494.","journal-title":"Autophagy"},{"issue":"1","key":"8163_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12967-023-04270-9","volume":"21","author":"ZDZ Su","year":"2023","unstructured":"Su ZDZ, Li CQ, Wang HW, Zheng MM, Chen QW. Inhibition of DRP1-dependent mitochondrial fission by Mdivi-1 alleviates atherosclerosis through the modulation of M1 polarization. J Transl Med. 2023;21(1):427. https:\/\/doi.org\/10.1186\/s12967-023-04270-9.","journal-title":"J Transl Med"},{"key":"8163_CR25","doi-asserted-by":"publisher","first-page":"103918","DOI":"10.1016\/j.redox.2025.103918","volume":"88","author":"Q Wu","year":"2025","unstructured":"Wu Q, Cai Y, Yan Z, Wang Y, Liu J, Guan X, et al. Redox-sensitive m6A regulation in atherosclerosis: METTL3 at the crossroads of mitochondrial quality control and pyroptosis. Redox Biol. 2025;88:103918. https:\/\/doi.org\/10.1016\/j.redox.2025.103918.","journal-title":"Redox Biol"},{"issue":"6","key":"8163_CR26","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3892\/ijmm.2020.4746","volume":"46","author":"Y Qin","year":"2020","unstructured":"Qin Y, Li L, Luo E, Hou J, Yan G, Wang D, et al. Role of m6A RNA methylation in cardiovascular disease (Review). Int J Mol Med. 2020;46(6):1958\u201372. https:\/\/doi.org\/10.3892\/ijmm.2020.4746.","journal-title":"Int J Mol Med"},{"issue":"7","key":"8163_CR27","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/cvr\/cvab160","volume":"118","author":"R Kumari","year":"2022","unstructured":"Kumari R, Ranjan P, Suleiman ZG, Goswami SK, Li J, Prasad R, et al. Verma SK: mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification. Cardiovasc Res. 2022;118(7):1680\u201392. https:\/\/doi.org\/10.1093\/cvr\/cvab160.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"8163_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1161\/CIRCULATIONAHA.118.036146","volume":"139","author":"LE Dorn","year":"2019","unstructured":"Dorn LE, Lasman L, Chen J, Xu X, Hund TJ, Medvedovic M, et al. The N 6 -methyladenosine mRNA Methylase METTL3 controls cardiac homeostasis and Hypertrophy. Circulation. 2019;139(4):533\u201345. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036146.","journal-title":"Circulation"},{"issue":"1","key":"8163_CR29","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/s41467-024-46357-x","volume":"15","author":"T Zhuang","year":"2024","unstructured":"Zhuang T, Chen MH, Wu RX, Wang J, Hu XD, Meng T, et al. ALKBH5-mediated m6A modification of IL-11 drives macrophage-to-myofibroblast transition and pathological cardiac fibrosis in mice. Nat Commun. 2024;15(1):1995. https:\/\/doi.org\/10.1038\/s41467-024-46357-x.","journal-title":"Nat Commun"},{"issue":"10","key":"8163_CR30","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1681\/ASN.0000000000000428","volume":"35","author":"YC Tsai","year":"2024","unstructured":"Tsai YC, Hsieh TH, Liao YR, Tsai MT, Lin TP, Lee DY, et al. METTL3-mediated N 6 -methyladenosine mRNA modification and cGAS-STING pathway activity in kidney fibrosis. JASN. 2024;35(10):1312\u201329. https:\/\/doi.org\/10.1681\/ASN.0000000000000428.","journal-title":"JASN"},{"issue":"1","key":"8163_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13148-024-01736-5","volume":"16","author":"M Tan","year":"2024","unstructured":"Tan M, Liu S, Liu L. N6-methyladenosine (m6A) RNA modification in fibrosis and collagen-related diseases. Clin Epigenet. 2024;16(1):127. https:\/\/doi.org\/10.1186\/s13148-024-01736-5.","journal-title":"Clin Epigenet"},{"issue":"1","key":"8163_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s00011-025-02109-1","volume":"74","author":"J Leng","year":"2025","unstructured":"Leng J, Cao Z, Li L, Hu D, Luo Y, Tu B, et al. PGC1\u03b1 alleviates M1 macrophage polarization through dual regulation of succinate metabolism and TRAF5 expression to mitigate TLR4\/NF-\u03baB-driven inflammatory cascades and myocardial ischemia\/reperfusion injury. Inflamm Res. 2025;74(1):156. https:\/\/doi.org\/10.1007\/s00011-025-02109-1.","journal-title":"Inflamm Res"},{"issue":"9","key":"8163_CR33","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/nm.2439","volume":"17","author":"G Haemmerle","year":"2011","unstructured":"Haemmerle G, Moustafa T, Woelkart G, B\u00fcttner S, Schmidt A, van de Weijer T, et al. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-\u03b1 and PGC-1. Nat Med. 2011;17(9):1076\u201385. https:\/\/doi.org\/10.1038\/nm.2439.","journal-title":"Nat Med"},{"key":"8163_CR34","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.ijbiomac.2022.11.042","volume":"223","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Song K, Tu B, Sun H, Ding JF, Luo Y, et al. METTL3 boosts glycolysis and cardiac fibroblast proliferation by increasing AR methylation. Int J Biol Macromolecules. 2022;223:899\u2013915. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.11.042.","journal-title":"Int J Biol Macromolecules"},{"key":"8163_CR35","doi-asserted-by":"publisher","first-page":"102820","DOI":"10.1016\/j.redox.2023.102820","volume":"65","author":"ZY Liu","year":"2023","unstructured":"Liu ZY, Song K, Tu B, Lin LC, Sun H, Zhou Y, et al. Crosstalk between oxidative stress and epigenetic marks: new roles and therapeutic implications in cardiac fibrosis. Redox Biol. 2023;65:102820. https:\/\/doi.org\/10.1016\/j.redox.2023.102820.","journal-title":"Redox Biol"},{"issue":"1","key":"8163_CR36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00018-024-05516-5","volume":"81","author":"SX Jiang","year":"2024","unstructured":"Jiang SX, Zhou ZY, Tu B, Song K, Lin LC, Liu ZY, et al. Tao H: epigenetic regulation of mitochondrial fission and cardiac fibrosis via sFRP3 promoter methylation. Cell. Mol. Life Sci. 2024;81(1):483. https:\/\/doi.org\/10.1007\/s00018-024-05516-5.","journal-title":"Cell. Mol. Life Sci"},{"key":"8163_CR37","doi-asserted-by":"publisher","unstructured":"Chen HJ, Pan X-X XX, Ding LLQ, Ruan CC, PJ. Cardiac fibroblast-specific knockout of PGC-1\u03b1 accelerates AngII-Induced cardiac remodeling. Front. Cardiovasc. Med. 2021;8:664626. https:\/\/doi.org\/10.3389\/fcvm.2021.664626.","DOI":"10.3389\/fcvm.2021.664626"},{"issue":"3","key":"8163_CR38","doi-asserted-by":"publisher","first-page":"101058","DOI":"10.1016\/j.jbc.2021.101058","volume":"297","author":"X Zhang","year":"2021","unstructured":"Zhang X, Li X, Jia H, An G, Ni J. The m6A methyltransferase METTL3 modifies PGC-1\u03b1 mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes. J Biol Chem. 2021;297(3):101058. https:\/\/doi.org\/10.1016\/j.jbc.2021.101058.","journal-title":"J Biol Chem"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08163-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08163-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08163-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:48:53Z","timestamp":1781135333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08163-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8163"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08163-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read the manuscript and provided their consent for the submission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"753"}}